Irony T, Gonzalez Sepulveda JM, Poulos C, Wilson L. Three FDA CBER-sponsored quantitative patient preference studies of biologic treatments to inform regulatory decision making. Presented at the 2020 DIA Virtual Conference; June 15, 2020. Washington, DC.